P21 is what I would call a true brain health peptide. It’s not a nootropic in the classic “stimulant” sense, and it’s definitely not a limitless-pill type compound. Instead, it works upstream, supporting the brain by upregulating BDNF, enhancing neurogenesis, improving synaptic connectivity, and reducing neuroinflammation.

I first heard about P21 years ago through parents of neurodivergent children who were experimenting with intranasal use and seeing meaningful changes. That sent me down the research rabbit hole. Since then, I’ve used it personally, worked with others using it, and spent a lot of time reviewing the animal data behind it.

In this episode, I break down what P21 actually is, how it works mechanistically, why it’s often compared to Cerebrolysin (and why it’s very different), and where I see its real-world use cases. We talk memory, neurogenesis, Alzheimer’s and Down syndrome animal models, traumatic brain injury, vision effects, dosing strategies, safety data, and how I personally cycle it.

This isn’t hype. There are no human trials yet. But the preclinical data is compelling, and in a world where sourcing Cerebrolysin is harder than ever, P21 stands out as a lighter, more accessible tool for long-term brain health.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app

Home Top podcasts Popular guests Top books